Failure of recombinant factor VIIa in a patient with severe sepsis and bleeding
Author Information
Author(s): Anna Conen, Maja Weisser, Dimitrios A Tsakiris, Martin Siegemund
Primary Institution: University Hospital, Basel, Switzerland
Hypothesis
Can recombinant factor VIIa effectively control bleeding in patients with severe polymicrobial sepsis?
Conclusion
The off-label use of recombinant factor VIIa may lead to more side effects than expected due to publication bias, and there is a need for guidelines on its use.
Supporting Evidence
- The patient had severe intraabdominal bleeding after surgery despite treatment.
- Recombinant factor VIIa was administered but did not stop the bleeding.
- The patient died from multiorgan failure due to septic and hemorrhagic shock.
Takeaway
This study talks about a very sick man who didn't get better after using a special medicine to stop his bleeding, showing that sometimes treatments don't work as hoped.
Methodology
Case report of a single patient treated with recombinant factor VIIa for uncontrolled bleeding.
Potential Biases
Potential publication bias may overestimate the efficacy of rFVIIa.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
54-year-old male with severe polymicrobial sepsis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website